ns 1619 has been researched along with Endometrial Neoplasms in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
Endometrial Neoplasms: Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N | 1 |
| Liu, L | 1 |
| Li, G | 1 |
| Xia, M | 1 |
| Du, C | 1 |
| Zheng, Z | 1 |
1 other study available for ns 1619 and Endometrial Neoplasms
| Article | Year |
|---|---|
The role of BKCa in endometrial cancer HEC-1-B cell proliferation and migration.
Topics: Benzimidazoles; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endometrial Neoplasms; Female; | 2018 |